← Back to Search

Behavioral Intervention

Mindfulness for Human Immunodeficiency Virus Infection

N/A
Waitlist Available
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately post-intervention
Awards & highlights

Study Summary

This trial will test a mindfulness-based stress reduction intervention among African American/Black women with HIV to assess feasibility and acceptability.

Eligible Conditions
  • Human Immunodeficiency Virus (HIV) Infection
  • Mild Cognitive Impairment

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately post-intervention or 8 weeks.
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately post-intervention or 8 weeks. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability
Feasibility of the mindfulness intervention in women with mild cognitive impairment
Neurocognitive Function
Secondary outcome measures
Medication Adherence
Mental Distress
Perceived Stress

Trial Design

2Treatment groups
Experimental Treatment
Group I: Usual CareExperimental Treatment1 Intervention
The control condition will continue receiving usual care or standard of care.
Group II: Mindfulness-based Stress ReductionExperimental Treatment1 Intervention
Mindfulness-based stress reduction sessions received by the treatment group will include an orientation, approximately 8 intervention sessions, and an exit interview.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness
2014
Completed Phase 3
~2670

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,594 Previous Clinical Trials
2,282,449 Total Patients Enrolled
~9 spots leftby Jun 2025